Foundation to host live webinar on key findings of the 2026 Access to Medicine Index
Date
26 January 2027
Location
Online
The 2026 Access to Medicine Index, set for publication in November, will mark a 20-year milestone in tracking pharma company action on global health equity.
With funding constraints, geopolitical instability and rising health needs putting increasing pressure on the global health ecosystem – especially in lower-resource settings – action from pharma companies is more important than ever to ensure vulnerable populations aren’t left behind.
The report pinpoints opportunities for companies and other global health actors to build on years of momentum and bridge longstanding gaps, ensuring access catches up with innovation.
About the webinar
The Foundation is hosting a live, one-hour webinar to deep dive into the Key Findings of the 2026 Access to Medicine Index, ensuring representatives of pharmaceutical companies assessed by the Index are equipped to take action on access gaps. Marijn Verhoef, Director of Private Sector Engagement, and Pauline l'Henaff, Head of Industry Engagement, at the Access to Medicine Foundation, will cover:
Pharmaceutical industry performance in expanding access to medicine in low- and middle-income countries;
Areas of progress and areas for improvement;
Other key insights from this special 10th edition of the Index.
The webinar will feature a presentation followed by a Q&A session, with attendees encouraged to ask questions and deep dive into the practical implications of the findings.